
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
I am inherently skeptical of rules. But I also appreciate their potential value. Many rules are good and intended to ensure societal order, support justice and minimize error. I'm especially a fan of well-designed rules intended to control the strong personal gain incentive. But complex rules incorporate details that the devil loves to manipulate.






